Company news
Euroapi Sa (EURONEXT:EAPI) news
Every Euroapi Sa press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
EUROAPI : Rapport financier semestriel 2026
July 31, 2026
EUROAPI : Availability of 2026 Half-year results financial report
July 31, 2026
EUROAPI_Mise à disposition du Rapport Financier Semestriel 2026
July 30, 2026
First-Half 2026 results confirm commercial and operational resilience in a challenging market environment - Transformation progressing as...
July 28, 2026
Combined General Meeting of May 27, 2026
May 27, 2026
Assemblée Générale Mixte du 27 mai 2026
May 26, 2026
EUROAPI_Liquidity Contract
April 30, 2026
Availabilty of 2026 AGM preparatory documents
April 29, 2026
EUROAPI : Availability of the 2025 Universal Registration Document, including the Annual Financial Report
March 27, 2026
2025 results: Core EBITDA margin improved despite sales headwinds, driven by strong cost discipline
March 3, 2026
Market update
December 16, 2025
Tristan Imbert co-opted as Independent Director
December 10, 2025
With Med4Cure, EUROAPI accelerates pharmaceutical innovation at the service of health sovereignty
October 23, 2025
Change in Board’s Composition
September 30, 2025
Science Based Targets initiative (SBTi) validates EUROAPI’s near-term climate targets
September 18, 2025
Availability of 2025 Half-Year Financial Report
July 31, 2025
EUROAPI : H1 2025 Results Presentation (euroapi h1 2025 results presentation)
July 30, 2025
First-half 2025 results
July 29, 2025
EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 transformation plan
June 30, 2025
Frédéric Robert appointed EUROAPI’s Chief Commercial Officer overseeing API Solutions and CDMO activities
June 4, 2025
Combined General Meeting of May 21, 2025
May 21, 2025
Combined General Meeting of May 21, 2025 - Availability of preparatory documents
April 29, 2025